The Globe and Mail and CTV News recently published reports indicating that MV140, Red Leaf Medical’s sublingual vaccine for the prevention of recurrent urinary tract infections in women, is awaiting Health Canada approval. The news items explain the impact of UTIs on women’s health and how the antibiotics used to treat them are contributing to antimicrobial resistance. Read the online CTV story and watch the video of the story that aired on their broadcast. The Globe and Mail article was published on February 27, 2023.
Vaccine for UTIs awaiting approval by Health Canada | CTV News